Jamjoom Pharmaceuticals Factory Company

Historical price data

Jamjoom Pharma's mission is to provide high-quality, affordable pharmaceutical products to the Saudi and MENA markets, directly supporting national goals of healthcare self-sufficiency. The company has achieved a dominant position as a top-tier local manufacturer, evidenced by its substantial $10.08B market valuation and extensive product portfolio across key therapeutic areas. Its strategy centers on leveraging its WHO-GMP certified manufacturing infrastructure, expanding its branded generics portfolio, and capitalizing on favorable government policies to drive growth. Jamjoom operates a vertically integrated model combining production with a robust distribution network for both its own products and third-party partners.

Advanced pharmaceutical manufacturing and formulation platform focused on developing, optimizing, and producing high-quality branded generic drugs across multiple dosage forms, supported by WHO-GMP certified facilities and deep regulatory expertise.

Jamjoom competes directly with other local Saudi manufacturers (e.g., SPIMACO, Tabuk) for government tenders and market share, while simultaneously partnering with and distributing for multinational pharmaceutical companies. Its competitive advantages include first-mover scale, strategic alignment with national policy, an integrated distribution network, and a longstanding reputation for quality.